These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 14758941)

  • 1. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA; Armstrong D; Vachhrajani S; Dirks PB
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pial synangiosis in patients with moyamoya younger than 2 years of age.
    Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
    J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
    Jecko V; Penchet G; Champeaux C
    Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
    Chen C; Wang H; Hou B; Luo L; Guo Y
    World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
    Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
    Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
    Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
    J Neurosurg Pediatr; 2019 Apr; 23(4):493-497. PubMed ID: 30717056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of disease in unilateral moyamoya syndrome.
    Smith ER; Scott RM
    Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2021 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pial synangiosis for moyamoya syndrome in children.
    Adelson PD; Scott RM
    Pediatr Neurosurg; 1995; 23(1):26-33. PubMed ID: 7495663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorea in the clinical presentation of moyamoya disease: results of surgical revascularization and a proposed clinicopathological correlation.
    Ahn ES; Scott RM; Robertson RL; Smith ER
    J Neurosurg Pediatr; 2013 Mar; 11(3):313-9. PubMed ID: 23289915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.